Procter & Gamble Company (The) $PG Shares Sold by Boston Trust Walden Corp

Boston Trust Walden Corp reduced its holdings in Procter & Gamble Company (The) (NYSE:PG) by 16.3% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 428,798 shares of the company’s stock after selling 83,321 shares during the period. Boston Trust Walden Corp’s holdings in Procter & Gamble were worth $65,885,000 at the end of the most recent quarter.

Other institutional investors have also recently made changes to their positions in the company. Nova Wealth Management Inc. acquired a new stake in Procter & Gamble during the 1st quarter worth about $26,000. Halbert Hargrove Global Advisors LLC purchased a new stake in shares of Procter & Gamble in the third quarter worth about $25,000. Signature Resources Capital Management LLC grew its holdings in Procter & Gamble by 67.9% during the second quarter. Signature Resources Capital Management LLC now owns 178 shares of the company’s stock worth $28,000 after acquiring an additional 72 shares during the period. Quarry LP purchased a new position in Procter & Gamble during the first quarter valued at approximately $33,000. Finally, Mid American Wealth Advisory Group Inc. purchased a new position in Procter & Gamble during the second quarter valued at approximately $34,000. Hedge funds and other institutional investors own 65.77% of the company’s stock.

Procter & Gamble Stock Performance

PG opened at $144.54 on Tuesday. The firm’s fifty day simple moving average is $146.66 and its two-hundred day simple moving average is $152.58. Procter & Gamble Company has a 52-week low of $138.14 and a 52-week high of $179.99. The company has a market cap of $337.74 billion, a price-to-earnings ratio of 21.10, a PEG ratio of 4.88 and a beta of 0.39. The company has a quick ratio of 0.51, a current ratio of 0.71 and a debt-to-equity ratio of 0.46.

Procter & Gamble (NYSE:PG) last released its quarterly earnings results on Friday, October 24th. The company reported $1.99 earnings per share for the quarter, topping the consensus estimate of $1.90 by $0.09. The firm had revenue of $22.39 billion during the quarter, compared to the consensus estimate of $22.23 billion. Procter & Gamble had a net margin of 19.74% and a return on equity of 32.63%. The company’s revenue for the quarter was up 3.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $1.93 EPS. Procter & Gamble has set its FY 2026 guidance at 6.830-7.100 EPS. Equities analysts anticipate that Procter & Gamble Company will post 6.91 earnings per share for the current fiscal year.

Procter & Gamble Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Monday, November 17th. Stockholders of record on Friday, October 24th were given a $1.0568 dividend. This represents a $4.23 annualized dividend and a dividend yield of 2.9%. The ex-dividend date was Friday, October 24th. Procter & Gamble’s dividend payout ratio (DPR) is 61.61%.

Insider Transactions at Procter & Gamble

In related news, insider Susan Street Whaley sold 2,408 shares of the business’s stock in a transaction that occurred on Thursday, October 2nd. The stock was sold at an average price of $152.23, for a total transaction of $366,569.84. Following the completion of the sale, the insider directly owned 31,770 shares in the company, valued at approximately $4,836,347.10. The trade was a 7.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, COO Shailesh Jejurikar sold 3,986 shares of the firm’s stock in a transaction on Thursday, October 2nd. The shares were sold at an average price of $152.23, for a total value of $606,788.78. Following the completion of the transaction, the chief operating officer owned 46,899 shares in the company, valued at $7,139,434.77. The trade was a 7.83% decrease in their position. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders sold 30,308 shares of company stock valued at $4,611,852. Insiders own 0.20% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently commented on the stock. Berenberg Bank raised their price objective on shares of Procter & Gamble from $152.00 to $154.00 and gave the stock a “hold” rating in a research note on Wednesday, September 17th. Morgan Stanley set a $175.00 price target on shares of Procter & Gamble in a report on Monday, October 27th. JPMorgan Chase & Co. dropped their price target on shares of Procter & Gamble from $165.00 to $157.00 and set a “neutral” rating on the stock in a research report on Thursday, December 18th. BNP Paribas Exane decreased their price objective on shares of Procter & Gamble from $177.00 to $172.00 and set an “outperform” rating for the company in a research report on Tuesday, September 23rd. Finally, Weiss Ratings restated a “hold (c)” rating on shares of Procter & Gamble in a research report on Monday, December 22nd. Thirteen analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and a consensus target price of $171.38.

Procter & Gamble Profile

Procter & Gamble (NYSE: PG) is a multinational consumer goods company headquartered in Cincinnati, Ohio. Founded in 1837 by William Procter and James Gamble, P&G has grown into one of the world’s largest producers of branded consumer packaged goods. The company focuses on developing, manufacturing and marketing a broad portfolio of household and personal care products sold to consumers and retailers worldwide.

P&G’s product offering spans several core business categories, including Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care.